← Leaderboards
Jing Jin
Northwestern University At Chicago
$2,478,802
Attributed
$4,523,103
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,523,103 · 3
By mechanism
R01$4,088,603 · 2
R21$434,500 · 1
Top collaborators
- Susan E Quaggin4 shared
- Ming Zhao3 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Rupal Mehta$999,759
- Benjamin R. Thomson$2,004,347
- Jimmy Su$76,738
Others in their field
Other Emerging Leaders on “Molecular”
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,360,557
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$109,548,439
- Leonard Freedmand · Leidos Biomedical Research, Inc.$85,594,314
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Scott Hensley · University Of Pennsylvania$41,662,743
Research focus
MolecularCellsDesignInsightMouse ModelLeadClinicStructureLigandsLiquid SubstanceDefectTissuesMapsFamilyPathogenesisBlood VesselsAngpt1 GeneCell DeathChildhoodClinical DevelopmentBiomedical EngineeringAnterior ChamberAngiopoietinsCell Survival
Grant awards (9)
Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses$579,236
R01 · FY2025 · EB · contact PI
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma$600,978
R01 · FY2024 · EY
Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses$565,566
R01 · FY2024 · EB · contact PI
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma$600,978
R01 · FY2023 · EY
Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses$577,163
R01 · FY2023 · EB · contact PI
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma$582,949
R01 · FY2022 · EY
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma$581,733
R01 · FY2021 · EY
A Master Role of Symmetric Arginine Dimethylation in Lupus Autoantibody Response$197,500
R21 · FY2019 · AI · contact PI
A Master Role of Symmetric Arginine Dimethylation in Lupus Autoantibody Response$237,000
R21 · FY2018 · AI · contact PI